Related Experiment Video
Updated: Aug 19, 2025
06:10
Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice
Published on: September 16, 2020
2.4K
Celastrol enhances bone wound healing in rats
Acta Biochimica Polonica
|December 2, 2022
Summary
Celastrol effectively promotes bone fracture healing in rats by improving bone mineral density and mechanical properties. This natural compound shows promise as a therapeutic agent for bone injuries.
Area of Science:
- Orthopedics and Traumatology
- Pharmacology and Toxicology
- Biochemistry and Molecular Biology
Background:
- Bone fractures are prevalent injuries impacting the musculoskeletal system.
- Effective therapeutic strategies for accelerating bone healing are crucial.
Purpose of the Study:
- To investigate the efficacy of celastrol in promoting bone wound healing in a rat model.
- To assess the impact of celastrol on bone metabolism and inflammatory markers.
Main Methods:
- Sprague-Dawley rats with induced bone wounds were treated with low (10 μg/kg) and high (100 μg/kg) doses of celastrol for 14 days.
- Evaluated serum calcium, phosphorus, alkaline phosphatase, bone mechanical properties, bone mineral density (BMD), and protein expression via Western blot.
Main Results:
- Celastrol administration, particularly at high doses, significantly enhanced fracture strength, elastic load, bending energy, and BMD.
- High-dose celastrol increased serum calcium and alkaline phosphatase levels.
- Celastrol modulated osteogenesis markers (OPG, COL-1) and downregulated key inflammatory cytokines (IL-1α, IL-6, MCP-1), while upregulating IFN-γ.
Conclusions:
- Celastrol demonstrates significant therapeutic potential in promoting bone wound healing in rats.
- Further research into celastrol as a treatment for bone fractures is warranted.
